COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

Clinical trial NCT05584176 · COMPLETED

Trial details

NCT number: NCT05584176
Sponsor: MP Biomedicals, LLC
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

SARS-CoV2 Infection COVID-19

Start date: 2021-12-09
Primary completion: 2022-01-21
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.